Microsoft word - pns-bafps 48-veterinary drug mrls.doc

Veterinary drug residues in food: Maximum residue Foreword The formulation of this Philippine National Standards for Veterinary Drug Residues in Food: Maximum Residue Limits (MRLs) took into account MRLs set by the Codex Alimentarius Commission (CAC). The Bureau of Agriculture and Fisheries Product Standards pursued the adoption of the Codex MRLs as a national regulation to ensure harmonization at the international level and to establish food safety standard. BAFPS tapped various experts, stakeholders and agencies concerned to generate inputs, comments, and suggestions as a means of verification prior to the standards’ approval. PHILIPPINE NATIONAL STANDARD PNS/BAFPS 48:2007 Veterinary drug residues in food: Maximum residue limits (MRLs) 1 Records Benzylpenicillin/Procaine benzylpenicillin Applies to procaine benzylpenicillin only. Applies to procaine benzylpenicillin only. Applies to procaine benzylpenicillin only. The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied. The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied. Chlortetracycline/Oxytetracycline/Tetracycline Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases. Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases. Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases. Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases. Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases. Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases. Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases. Limit of quantitation of the analytical method. High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose. Depending on the route and/or time of administration the use of doramectin in dairy cows may result in extended withdrawal periods in milk. This may be addressed in national/regional regulatory programmes. High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Muscle including normal proportion of skin Additional MRL for skin with adhering fat of 300 µg/Kg. Additional MRL for skin with adhering fat of Very high concentration and great variation in the level of residues at the injection site in cattle over a 49 day period after dosing. JECFA evaluated the effect of pirlimycin residues on starter cultures and for this reason recommended an MRL of 100 µg/kg of milk. Codex Members may therefore adapt national/regional MRLs in order to address this technological aspect for trade of fresh liquid milk intended for processing using starter culture. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use. The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Source: http://spsissuances.da.gov.ph/attachments/article/729/PNS-BAFPS%2048-2007-veterinary%20drug%20MRLs.pdf